StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
NXGL

NEXGEL, Inc.

NXGL Nasdaq Surgical & Medical Instruments & Apparatus EDGAR ↗
$0.42
-0.02 -4.68%

Key statistics

from XBRL data in SEC filings
Market cap
$3.86M
Revenue (TTM)
$11.3M
Net income (TTM)
-$3.21M
EPS (TTM)
$-0.40
P/E ratio
Dividend yield
Free cash flow
-$1.38M
Cash
$2.12M
Total assets
$11.6M
Gross margin
38.9%
52-week range
$0.41 – $2.89

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Director or officer change Jul 29, 2026 8-K Other events Jul 9, 2026 8-K Director or officer change Jul 2, 2026 8-K Regulation FD disclosure Jun 17, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity May 15, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Director or officer change; Other events May 12, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 30, 2026 8-K Director or officer change; Other events Apr 30, 2026 8-K Delisting notice or listing-rule failure Apr 24, 2026 8-K Entered a material agreement; Completed an acquisition or disposition; Took on a direct financial obligation; Unregistered sale of equity; Other events Apr 21, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Entered a material agreement; Other events Mar 10, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure Feb 11, 2026 8-K Director or officer change Jan 30, 2026 8-K Director or officer change Jan 7, 2026 8-K Regulation FD disclosure Dec 11, 2025 8-K Other events Nov 24, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 12, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 12, 2025 8-K Director or officer change; Other events Aug 5, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Aug 1, 2025 8-K Regulation FD disclosure Jul 31, 2025 8-K Regulation FD disclosure Jul 14, 2025 8-K Director or officer change; Shareholder vote results Jun 20, 2025 8-K Regulation FD disclosure Jun 4, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Results of operations (earnings release) May 13, 2025 10-K Fiscal year ended 2024-12-31 Mar 27, 2025 8-K Regulation FD disclosure Mar 25, 2025 8-K Results of operations (earnings release) Mar 24, 2025 8-K Results of operations (earnings release) Jan 22, 2025 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change; Other events Jan 6, 2025 8-K Results of operations (earnings release) Nov 14, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Entered a material agreement; Other events Nov 12, 2024 8-K Regulation FD disclosure Oct 28, 2024 8-K Results of operations (earnings release) Oct 10, 2024